Emails going as far back as 2015 give a glimpse into the foundations of OpenAI and the early tensions at the company. Emails going as far back as 2015 give a glimpse into the foundations of OpenAI ...

Ferrari is set to introduce substantial upgrades on its SF-26 Formula 1 car at the Miami Grand Prix next week. The cancellation of the Bahrain and Saudi grands prix due to the Iran war has altered not ...

This quarter-mile drag race features a 790 horsepower Ferrari 812 Superfast going up against the Tesla Model X P100D. The ...

Elon Musk is boosting a post on X promoting The New Yorker’s extensive investigation into Sam Altman’s allegedly deceptive behavior, WIRED has confirmed. The move comes just as Musk’s lawsuit against ...

Good day, and thank you for standing by. Welcome to the Ferrari 2026 First Quarter Conference Call and Webcast. [Operator Instructions] Please be advised that today's conference is being recorded. I ...

Ferrari NV has settled on a preliminary price of about €550,000 ($647,000) for its first fully electric supercar ahead of the model’s premiere in Rome next month, according to people familiar with the ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

The U.S. Food and Drug Administration seeks to accelerate clinical trials of new medicines by using artificial intelligence to streamline the laborious process of collecting and submitting study data.

Mr. Musk’s posts on X have pushed his narrative that OpenAI has lost its way. By Ryan Mac Before opening statements began in the trial between Elon Musk and OpenAI on Tuesday, the world’s richest man ...

April 21 (Reuters) - Italian luxury sportscar maker Ferrari (RACE.MI), opens new tab has ‌settled on a preliminary price of about 550,000 euros ($647,130.00) for ⁠its first fully electric supercar, ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...